The Patent Finder
US

1H-Pyrazolo[3,4-b]pyridines and Therapeutic Uses Thereof

US 9,855,272 Lapsed on the fee record
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Sep 14, 2022 (Vickers Venture Fund VI Pte. Ltd.).

Lapsed Jan 2, 2026 on the fee record · High confidence

Second maintenance fee unpaid; grace period ended.

Filed Aug 23, 2016 as application 15/244,687 · Granted Jan 2, 2018
Base term, 20 years from filing
Today
Lapsed Jan 2, 2026
2010 2030
Clock starts
Dec 15, 2010
No longer in force
Jan 2, 2026
Granted
Jan 2, 2018
Term would have run to
Dec 15, 2030
base term after the term ends fee events Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
8
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

Its term would have run to Dec 15, 2030: its 20-year base term, with no adjustment for prosecution delay. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Dec 15, 2010, when application 12/968,505, the earliest non-provisional in its chain, was filed (this one was filed Aug 23, 2016)Dec 15, 2030High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidlapsed Jan 2, 2026High confidence
Computed term endThe steps above, in orderJan 2, 2026High confidence

This family

US 8,450,340In force
Sep 2031
Sep 2031
US 8,815,897Lapsed on the fee record
Aug 2026
Aug 2026
US 8,846,714Lapsed on the fee record
Sep 2026
Sep 2026
US 8,901,150In force
Dec 2030
Dec 2030
US 9,067,939In force
Dec 2030
Dec 2030
US 9,446,035In force
Dec 2030
Dec 2030
US 9,855,272this patent
Jan 2026
Jan 2026
US 10,105,370Lapsed on the fee record
Oct 2026
Oct 2026
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Sep 12, 2016
Reel 39696, frame 687
Hood, John; Kc, Sunil Kumar; Wallace, David MarkEpitherix, LLCAssignment of Assignor's Interest
Sep 12, 2016
Reel 39696, frame 748
Epitherix, LLCSamumed, LLCAssignment of Assignor's Interest
Mar 23, 2021
Reel 55693, frame 882
Samumed, LLCBiosplice Therapeutics, Inc.Assignment of Assignor's Interest
Sep 14, 2022
Reel 61433, frame 786
Biosplice Therapeutics, Inc.Vickers Venture Fund VI Pte. Ltd.; Vickers Venture Fund VI (Plan) Pte. Ltd.; Vickers-Splice Co.-Investment LLC; Med-Pathways II LimitedSecurity Interest
Sep 14, 2022
reel/frame not recorded
Biosplice Therapeutics, Inc.Vickers Venture Fund VI Pte. Ltd.Security Interest
Sep 14, 2022
reel/frame not recorded
Biosplice Therapeutics, Inc.Vickers Venture Fund VI (Plan) Pte. Ltd.Security Interest
Sep 14, 2022
reel/frame not recorded
Biosplice Therapeutics, Inc.Vickers-Splice Co.-Investment LLCSecurity Interest
Sep 14, 2022
reel/frame not recorded
Biosplice Therapeutics, Inc.Med-Pathways II LimitedSecurity Interest
Mar 12, 2026
Reel 75109, frame 434
TMF Group New York, LLC, Not Individually But Solely as Collateral AgentBiosplice Therapeutics, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited